CONMED Corporation (CNMD)
CONMED Corporation Announces Third Quarter 2025 Financial Results
Sutro Biopharma Inc (STRO)
Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025
Zevra Therapeutics, Inc. (ZVRA)
Zevra Reports Third Quarter 2025 Financial Results and Corporate Update
Talphera Inc (TLPH)
Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025
Revolution Medicines Inc (RVMDW)
Revolution Medicines Reports Third Quarter 2025 Financial Results and Update on Corporate Progress
Pacific Biosciences of California Inc (PACB)
PacBio Announces Third Quarter 2025 Financial Results
Revolution Medicines Inc (RVMD)
Revolution Medicines Reports Third Quarter 2025 Financial Results and Update on Corporate Progress
Dianthus Therapeutics Inc (DNTH)
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Design Therapeutics Inc (DSGN)
Design Therapeutics Announces Plans to Initiate Patient Dosing of DT-818 in Myotonic Dystrophy Type-1 (DM1) in the First Half of 2026 and Reports Third Quarter 2025 Financial Results
Rhythm Pharmaceuticals Inc (RYTM)
Rhythm Pharmaceuticals annonce le remboursement public de lIMCIVREE® (setmélanotide) au Canada dans cinq provinces et dans le cadre du Programme fédéral des services de santé non assurés